Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare Conference
26 févr. 2021 06h01 HE
|
Amphastar Pharmaceuticals, Inc.
RANCHO CUCAMONGA, Calif., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, Dan Dischner, V.P of Corporate Communications and...
Amphastar Announces Approval for Glucagon for Injection Kit, 1mg
29 déc. 2020 06h00 HE
|
Amphastar Pharmaceuticals, Inc.
RANCHO CUCAMONGA, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) has approved its Abbreviated...
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2020
06 nov. 2020 06h50 HE
|
Amphastar Pharmaceuticals, Inc.
RANCHO CUCAMONGA, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended September...
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2020
29 oct. 2020 16h05 HE
|
Amphastar Pharmaceuticals, Inc.
RANCHO CUCAMONGA, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its third quarter of 2020 ended...
Amphastar Pharmaceuticals Receives FDA Approval for Atropine Sulfate Injection
06 oct. 2020 06h00 HE
|
Amphastar Pharmaceuticals, Inc.
RANCHO CUCAMONGA, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) approved the Company’s...
Amphastar Pharmaceuticals to Present at the Wells Fargo 2020 Virtual Healthcare Conference
03 sept. 2020 16h05 HE
|
Amphastar Pharmaceuticals, Inc.
RANCHO CUCAMONGA, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, Dan Dischner, Vice President of Corporate...
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2020
06 août 2020 16h05 HE
|
Amphastar Pharmaceuticals, Inc.
RANCHO CUCAMONGA, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended June 30,...
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020
30 juil. 2020 16h05 HE
|
Amphastar Pharmaceuticals, Inc.
RANCHO CUCAMONGA, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its second quarter of 2020 ended June...
Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference
19 juin 2020 06h05 HE
|
Amphastar Pharmaceuticals, Inc.
RANCHO CUCAMONGA, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, Dan Dischner, Vice President of Corporate...
Amphastar Pharmaceuticals to Present at the Raymond James Virtual 2020 Human Healthcare Innovation Conference
12 juin 2020 06h30 HE
|
Amphastar Pharmaceuticals, Inc.
RANCHO CUCAMONGA, Calif., June 12, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, Dan Dischner, Vice President of Corporate...